Evidence map›Paper›PMID 38872309›Full record

ArticleHGG advances2024

Trait selection strategy in multi-trait GWAS: Boosting SNP discoverability.

Yuka Suzuki, Hervé Ménager, Bryan Brancotte, Raphaël Vernet, Cyril Nerin, Christophe Boetto, Antoine Auvergne, Christophe Linhard, Rachel Torchet, Pierre Lechat and 5 more

Abstract read
In one paragraph

Article in HGG advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Optimized phenotype definitions boost GWAS power.PLoS computational biology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Yuka SuzukiInstitut Pasteur, Université Paris Cité, Department of Computational Biology, 75015 Paris, France. Electronic address: yuka.en25@gmail.com.
Hervé MénagerInstitut Pasteur, Université Paris Cité, Bioinformatics of Biostatistics Hub, 75015 Paris, France.
Bryan BrancotteInstitut Pasteur, Université Paris Cité, Bioinformatics of Biostatistics Hub, 75015 Paris, France.
Raphaël VernetUniversité Paris Cité, Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-1124, Group of Genomic Epidemiology of Multifactorial Diseases, Paris, France.
Cyril NerinInstitut Pasteur, Université Paris Cité, Department of Computational Biology, 75015 Paris, France.
Christophe BoettoInstitut Pasteur, Université Paris Cité, Department of Computational Biology, 75015 Paris, France.
Antoine AuvergneInstitut Pasteur, Université Paris Cité, Department of Computational Biology, 75015 Paris, France.
Christophe LinhardUniversité Paris Cité, Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-1124, Group of Genomic Epidemiology of Multifactorial Diseases, Paris, France.
Rachel TorchetInstitut Pasteur, Université Paris Cité, Bioinformatics of Biostatistics Hub, 75015 Paris, France.
Pierre LechatInstitut Pasteur, Université Paris Cité, Bioinformatics of Biostatistics Hub, 75015 Paris, France.
Lucie TroubatInstitut Pasteur, Université Paris Cité, Department of Computational Biology, 75015 Paris, France.
Michael H ChoChanning Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Emmanuelle BouzigonUniversité Paris Cité, Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-1124, Group of Genomic Epidemiology of Multifactorial Diseases, Paris, France.
Hugues AschardInstitut Pasteur, Université Paris Cité, Department of Computational Biology, 75015 Paris, France. Electronic address: hugues.aschard@pasteur.fr.
Hanna JulienneInstitut Pasteur, Université Paris Cité, Department of Computational Biology, 75015 Paris, France; Institut Pasteur, Université Paris Cité, Bioinformatics of Biostatistics Hub, 75015 Paris, France. Electronic address: hanna.julienne@pasteur.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the first genome-wide association studies (GWASs), thousands of variant-trait associations have been discovered. However, comprehensively mapping the genetic determinant of complex traits through univariate testing can require prohibitive sample sizes. Multi-trait GWAS can circumvent this issue and improve statistical power by leveraging the joint genetic architecture of human phenotypes. Although many methodological hurdles of multi-trait testing have been solved, the strategy to select traits has been overlooked. In this study, we conducted multi-trait GWAS on approximately 20,000 combinations of 72 traits using an omnibus test as implemented in the Joint Analysis of Summary Statistics. We assessed which genetic features of the sets of traits analyzed were associated with an increased detection of variants compared with univariate screening. Several features of the set of traits, including the heritability, the number of traits, and the genetic correlation, drive the multi-trait test gain. Using these features jointly in predictive models captures a large fraction of the power gain of the multi-trait test (Pearson's r between the observed and predicted gain equals 0.43, p < 1.6 × 10

Indexed as

Genome-Wide Association StudyPhenotypePolymorphism, Single NucleotideHumansModels, GeneticQuantitative Trait, HeritableQuantitative Trait LociComplex traitsGenetic ArchitectureMulti-trait GWASStatistical powerVariant mapping

Identifiers

PMID38872309
PMCPMC11260573

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.